MedPath

LIPRELOG

LIPRELOG

Approved
DIN Number

02513374

Drug Class

Human

Market Date

N/A

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02513374
AIG Number0131614001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AB04 INSULIN LISPRO
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

INSULIN LISPROActive
Strength: 100 UNIT / ML
Monograph: INSULIN LISPRO

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.